BIBW2992
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIBW2992, covering 2022-02-02 to 2022-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients [Phase 2]